Avoiding Drug-Drug Interactions

Publisher： Karger

E-ISSN： 1421-9794|55|4|215-220

ISSN： 0009-3157

Source： Chemotherapy, Vol.55, Iss.4, 2009-05, pp. : 215-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug–Drug Interactions

By Weiss Johanna   Gajek Thomas   Köhler Bruno Christian   Haefeli Walter Emil  

Pharmaceutics, Vol. 8, Iss. 1, 2016-02 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Detection of Potential Drug-Drug Interactions for Outpatients across Hospitals

By Yeh Yu-Ting   Hsu Min-Hui   Chen Chien-Yuan   Lo Yu-Sheng   Liu Chien-Tsai  

International Journal of Environmental Research and Public Health, Vol. 11, Iss. 2, 2014-01 ,pp. : 1369-1383

MDPI

Access to resources Recommend Favorite

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

By Klatt Sabine   Fromm Martin F.   König Jörg  

Pharmaceutics, Vol. 3, Iss. 4, 2011-10 ,pp. : 680-705

MDPI

Access to resources Recommend Favorite

Vincristine-Induced Neuropathy in the Rat Is Not Modified by Drug-Drug Interactions with the P-Glycoprotein Inhibitor Verapamil

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 336-342

Karger

Access to resources Recommend Favorite

Evidence of Different Profiles of Side Effects and Drug–Drug Interactions among the Quinolones _ The Pharmacokinetic Standpoint

By  

Chemotherapy, Vol. 47, Iss. 3, 2001-09 ,pp. : 24-31

Karger

Access to resources Recommend Favorite